Patents by Inventor Quoc Tuan DO

Quoc Tuan DO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF NGAL PROTEIN
    Publication number: 20220054493
    Abstract: This invention relates to compounds that are inhibitors of NGAL activity, and applications thereof.
    Type: Application
    Filed: March 6, 2020
    Publication date: February 24, 2022
    Inventors: Frédéric JAISSER, Ernesto MARTINEZ-MARTINEZ, Paul MULDER, Antoine OUVRARD-PASCAUD, Philippe BERNARD, Quoc Tuan DO
  • Natural compounds and fibrosis
    Patent number: 11185539
    Abstract: The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: November 30, 2021
    Assignee: MEDIZINISCHE HOCHSCHULE HANNOVER (MHH)
    Inventors: Thomas Thum, Katharina Schimmel, Quoc-Tuan Do, Philippe Bernard
  • Dermocosmetic or pharmaceutical use of a composition comprising at least one inhibitor of some chemoattractant cytokines
    Patent number: 10828309
    Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: November 10, 2020
    Assignees: GREENPHARMA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE STRASBOURG
    Inventors: Philippe Bernard, Dayana Abboud, Jean-Luc Galzi, Nelly Frossard, Christelle Pillard, Quoc Tuan Do
  • NATURAL COMPOUNDS AND FIBROSIS
    Publication number: 20190350923
    Abstract: The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.
    Type: Application
    Filed: January 29, 2018
    Publication date: November 21, 2019
    Inventors: Thomas Thum, Katharina Schimmel, Quoc-Tuan Do, Philippe Bernard
  • DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION COMPRISING AT LEAST ONE INHIBITOR OF SOME CHEMOATTRACTANT CYTOKINES
    Publication number: 20170296547
    Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 19, 2017
    Inventors: Philippe BERNARD, Dayana ABBOUD, Jean-Luc GALZI, Nelly FROSSARD, Christelle PILLARD, Quoc Tuan DO
  • DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES
    Publication number: 20170281653
    Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 5, 2017
    Inventors: Philippe BERNARD, Dayana ABBOUD, Jean-Luc GALZI, Nelly FROSSARD, Christelle PILLARD, Quoc Tuan DO